Rigel Pharmaceuticals has seen its fair value estimate nudged up from US$49.60 to US$51.20, with only a small adjustment to the discount rate from 7.12% to 7.14% and revenue growth assumptions kept at ...

SOUTH SAN FRANCISCO, Calif., Jan. 9, 2025 /PRNewswire/ -- Rigel Pharmaceuticals (RIGL), Inc. , a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced ...

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 6: Rigel ...

*NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way. Total costs and expenses were $40 ...

Dose expansion phase will determine the recommended Phase 2 dose of R289 for patients with transfusion dependent R/R lower-risk MDS SOUTH SAN FRANCISCO, Calif., Oct. 8, 2025 /PRNewswire/ -- Rigel ...

SOUTH SAN FRANCISCO, Calif., June 3, 2020 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that data related to R835, the company's investigational IRAK1/4 inhibitor, will be ...

Rigel Protocol recently launched one of the most profitable crypto yield farming programs on the Binance Smart Chain decentralized finance space with up to 1,600% APY in the RGP-BNB alongside other ...

Dubbed Project Rigel, the mobile app will let people retouch photos on iPhones and iPads. It is slated to make its debut at Adobe's conference for digital creators in October. Stephen Shankland worked ...